
    
      A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study
      to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral AZD8329
      after Administration of Multiple Ascending Doses in Abdominally Obese but otherwise Healthy
      Male Subjects
    
  